These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 895494)

  • 1. [Correlation between products of fibrin degradation and platelet dysfunction in chronic renal failure. Effects of aspirin].
    Lazzari MA; Pavlovsky M; Martínez Canaveri A
    Medicina (B Aires); 1977; 37(2):97-105. PubMed ID: 895494
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet dysfunction and end-stage renal disease.
    Kaw D; Malhotra D
    Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vein fibrin degradation products (FDP's) in glomerulonephritis.
    Tomura S; Ideura T; Ida T; Osaka Y; Kuriyama R; Abe T; Takeuchi J
    Clin Nephrol; 1979 Dec; 12(6):248-53. PubMed ID: 527278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N
    Vutr Boles; 1978; 17(3):41-5. PubMed ID: 150133
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet aggregation in chronic renal failure].
    Sánchez Casajús A; Lasierra J; Viladés E
    Rev Clin Esp; 1979 Apr; 153(2):137-41. PubMed ID: 482679
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
    Gordge MP; Faint RW; Rylance PB; Ireland H; Lane DA; Neild GH
    Thromb Haemost; 1989 Jun; 61(3):522-5. PubMed ID: 2799764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
    Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
    Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in blood coagulation in glomerulonephritis].
    Robeva R; Belovezhdov N; Genova V
    Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemostaseopathies in chronic, azotemic renal insufficiency. Pathogenesis, diagnosis, treatment (author's transl)].
    Marx R; Murr H; Oey LS; Schramm W; Dobbelstein H
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1295-1300. PubMed ID: 819787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Congenital and acquired thrombocyte function disorders].
    Willoughby ML
    Kinderarztl Prax; 1980 Jul; 48(7):337-51. PubMed ID: 7001130
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet function in renal failure.
    Eknoyan G; Wacksman SJ; Glueck HI; Will JJ
    N Engl J Med; 1969 Mar; 280(13):677-81. PubMed ID: 5766077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnosis of the prethrombotic state in clinical practice].
    Makatsariia AD; Mishchenko AL
    Sov Med; 1982; (6):56-60. PubMed ID: 6750807
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood disorders. Introduction.
    Sweet DL; Jacobson LO
    Compr Ther; 1976 Apr; 2(4):9-11. PubMed ID: 1261219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet factor 3 (P-F-3) in chronic renal failure. Effect of dialysis].
    Lasierra Cirujeda J; Sánchez Casajus A; Vilades Juan E
    Rev Clin Esp; 1980 Mar; 156(5):321-4. PubMed ID: 7384579
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I; Sabovic M; Salobir B; Buturovic Ponikvar J
    Ren Fail; 2008; 30(6):597-602. PubMed ID: 18661409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of blood clotting factors in anaphylactic and primary and secondary endotoxin shock.
    Ferrell WJ; Jabs CM; Robb HJ; Mammen EF
    Ann Clin Lab Sci; 1983; 13(4):291-8. PubMed ID: 6194736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
    Gareau R; Gagnon MG; Ayotte C; Chénard C; Brisson GR
    Thromb Haemost; 1993 Aug; 70(2):373-4. PubMed ID: 8236152
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer techniques in the study of hemostatic disorders.
    Pepper DS; Preston FE; Mibashan RS
    Semin Hematol; 1978 Jan; 15(1):73-92. PubMed ID: 341329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.